Shojaei Shayan, Radkhah Hanieh, Azarboo Alireza, Soltani Pedram, Esteki Sadaf, Mousavi Asma
Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Iran.
School of Medicine, Tehran University of Medical Sciences, Iran.
Clin Med Insights Endocrinol Diabetes. 2025 Sep 15;18:11795514251372702. doi: 10.1177/11795514251372702. eCollection 2025.
Insulin resistance (IR) contributes significantly to major adverse cardio-cerebrovascular events (MACCE), with the estimated glucose disposal rate (eGDR) serving as a novel marker for assessing IR. This systematic review and meta-analysis investigate the association between eGDR and MACCE outcomes, aiming to clarify its predictive value across different diabetes statuses.
We searched databases for studies examining the relationship between eGDR and MACCE, including myocardial infarction (MI), stroke, ischemic heart disease (IHD), cardiovascular disease (CVD), and all-cause mortality. We compared groups with the lowest versus highest eGDR. Hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated using random effect models. Subgroup analyses assessed eGDR efficacy by diabetes status.
Our search identified 16 studies with 198 626 participants. The group with the lowest eGDR had a significantly higher risk of MACCE compared to the group with the highest eGDR (HR = 2.21, 95% CI 1.17-4.18). Additionally, the group with the lowest eGDR had notably worse outcomes for all-cause mortality, MI, stroke, CVD, and IHD with HRs of 2.03 (95% CI 1.05-3.90), 1.82 (95% CI 1.30-2.55), 2.82 (95% CI 1.66-4.69), 2.95 (95% CI 1.99-4.37), and 7.97 (95% CI 2.57-24.73), respectively. Subgroup analyses revealed consistent results for CVD in both populations with diabetes and non-diabetes status, for stroke in the population with non-diabetes status, and for IHD in the population with diabetes.
Lower eGDR, indicating higher IR, is linked with a significantly increased risk of MACCE. This parameter could enhance risk stratification models for predicting MACCE. Further studies are needed to evaluate the clinical role of eGDR in managing cardio-cerebrovascular risk across subgroups.
胰岛素抵抗(IR)是导致主要心脑血管不良事件(MACCE)的重要因素,估计葡萄糖处置率(eGDR)可作为评估IR的新指标。本系统评价和荟萃分析旨在研究eGDR与MACCE结局之间的关联,以阐明其在不同糖尿病状态下的预测价值。
我们检索了多个数据库,以查找研究eGDR与MACCE之间关系的研究,包括心肌梗死(MI)、中风、缺血性心脏病(IHD)、心血管疾病(CVD)和全因死亡率。我们比较了eGDR最低组和最高组。使用随机效应模型计算风险比(HR)和95%置信区间(CI)。亚组分析按糖尿病状态评估eGDR的疗效。
我们的检索共纳入16项研究,涉及198626名参与者。与eGDR最高组相比,eGDR最低组发生MACCE的风险显著更高(HR = 2.21,95% CI 1.17 - 4.18)。此外,eGDR最低组在全因死亡率、MI、中风、CVD和IHD方面的结局明显更差,HR分别为2.03(95% CI 1.05 - 3.90)、1.82(95% CI 1.30 - 2.55)、2.82(95% CI 1.66 - 4.69)、2.95(95% CI 1.99 - 4.37)和7.97(95% CI 2.57 - 24.73)。亚组分析显示,在糖尿病和非糖尿病患者中,CVD的结果一致;在非糖尿病患者中,中风的结果一致;在糖尿病患者中,IHD的结果一致。
较低的eGDR表明较高的IR,与MACCE风险显著增加相关。该参数可改进预测MACCE的风险分层模型。需要进一步研究以评估eGDR在管理各亚组心脑血管风险中的临床作用。